By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Amerigen Pharmaceuticals 

197 Route 18 South, Suite 306 N

East Brunswick  New Jersey   08816  U.S.A.
Phone: 732-993-9827 Fax: n/a



Company News
Amerigen Pharmaceuticals Announces That Its ANDA For Carbidopa 25mg Tablets Has Received Final Approval From The FDA 3/12/2014 7:20:28 AM
Sinochem Jiangsu to Distribute Suzhou Amerigen Pharmaceuticals Drug in China 9/27/2013 9:26:34 AM
Amerigen Pharmaceuticals Today Announced Its Chinese Subsidiary, Suzhou Amerigen Pharmaceuticals Co., Ltd., Had Entered Into a Marketing and Distribution Agreement With Sinochem Jiangsu Pharmaceutical Co., Ltd. Regarding Amerigen's Generic Mecobalamin 0.5mg Immediate Release Tablets 9/26/2013 10:29:42 AM
Amerigen Pharmaceuticals Today Announced It Had Entered Into a Collaboration Agreement With Forest Laboratories, Inc. (FRX) Regarding the Development of a Number of Specialty Generic Products. 7/31/2013 10:06:06 AM
Amerigen Pharmaceuticals Announces ANDA Filing and BYSTOLIC(R) Patent Challenge 3/16/2012 9:37:06 AM
Amerigen Pharmaceuticals Announces Two China-US Deals 1/13/2012 9:33:09 AM
Amerigen Pharmaceuticals and VIWA Pharmaceutical Company Today Jointly Announce the Signing of a Memorandum of Understanding (MOU) Setting Out Their Intention to Establish a Joint Venture to Develop and Register a Range of Branded Generic Medicines for Sale in China 1/12/2012 10:21:57 AM
Amerigen Pharmaceuticals and the Shanghai Fosun Omni Pharmaceutical Company Enter Into Collaboration Agreement for the Development of Generic Oral Controlled Release Products 1/11/2012 12:06:45 PM
Amerigen Pharmaceuticals President and CEO to Present a Company Overview at the J.P. Morgan Healthcare Conference 1/5/2012 2:30:05 PM
Amerigen Pharmaceuticals and Stason Pharmaceuticals, Inc. Enter Into Collaboration Agreement for Development of Generic Oral Oncology Products 10/18/2011 11:23:17 AM